Leaflet CO-DOLNIX 16mg / 12.5mg tablets
Indicated for: hypertension
Route of administration: oral
Substance: desartan cilexetil + hydrochlorothiazide (antihypertensive + diuretic)
ATC: C09CA06 (Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain)
Dose adjustment may be needed in kidney disease.
This medicine may cause dizziness or vertigo.
Avoid excessive exposure to sunlight or UV radiation.
May lower blood pressure and increase the risk of falls.
Periodic laboratory tests may be required during treatment.
This medicine may change blood electrolyte levels.
The combination of Candesartan cilexetil + Hydrochlorothiazide is used for the treatment of essential hypertension in patients who do not respond adequately to monotherapy. It combines an angiotensin II receptor antagonist (candesartan cilexetil) with a thiazide diuretic (hydrochlorothiazide) to lower blood pressure.
The medication is taken orally, usually once daily, and is effective in reducing the risk of cardiovascular complications such as stroke or myocardial infarction.
Side effects may include dizziness, headache, nausea, hypokalemia, or increased uric acid levels. It is important to monitor blood pressure and kidney function during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Candesartan cilexetil + Hydrochlorothiazide. Follow the prescribed dosage and adhere to all medical recommendations.
General data about CO-DOLNIX 16mg / 12.5mg
- Substance: desartan cilexetil + hydrochlorothiazide
- Date of latest medicines list: 01-07-2013
- Product code: W56327001
- Concentration: 16mg / 12.5mg
- Pharmaceutical form: tablets
- Quantity: 28
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.